| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | — | 1 | — | — | 1 | — | — | — | — | — | 1 |
| total | individual payouts | |
|---|---|---|
| 2028 | ‡‡‡‡‡ |
|
| 2027 | ‡‡‡‡‡ |
|
| 2026 | 1.40 |
—
—
—
|
| 2025 | 1.40 |
—
—
—
—
|
| 2024 | 1.40 |
—
—
—
—
|
| 2023 | 1.38 |
—
—
—
—
|
| 2022 | 1.23 |
—
—
—
—
|
| 2021 | 1.00 |
—
—
—
—
|
| 2020 | 1.00 |
—
—
—
—
|
| 2019 | 1.36 |
—
—
—
—
|
| 2018 | 1.24 |
—
—
—
—
|
| 2017 | 1.24 |
—
—
—
—
|
| 2016 | 1.68 |
—
—
—
—
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 11,743.40 | 13,033.10 | 14,358.00 | 12,272.20 |
| Receivables | 832.60 | 1,042.70 | 1,041.20 | 1,471.50 |
| Inventory | — | — | — | — |
| Other | — | — | — | — |
| 12,576.00 | 14,075.80 | 15,399.20 | 13,743.70 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 609.70 | 631.70 | 747.60 | 834.80 |
| ST’ Debt | — | — | — | — |
| Other | — | — | — | — |
| 5,531.90 | 6,078.30 | 6,597.00 | 5,842.40 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡ | ‡‡‡ | ‡‡‡ |
| Earnings | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 254.00 | 1,123.50 | — | — |
—
|
| ’25 | 973.10 | 1,572.90 | 332.70 | 1,901.10 |
4,779.80
|
| ’24 | 688.40 | 1,069.70 | 2,635.20 | 1,032.50 |
5,425.80
|
| ’23 | 859.00 | 462.10 | 716.60 | 926.20 |
2,963.90
|
| ’22 | 1,581.80 | 1,049.00 | 1,088.50 | 719.40 |
4,438.70
|
| ’21 | 2,437.20 | 2,706.30 | 1,639.50 | 1,999.10 |
8,782.10
|
| ’20 | (745.70) | 1,131.00 | 1,034.60 | 1,514.70 |
2,934.60
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (1,242.40) | (0.50) | — | — |
—
|
| ’25 | (352.10) | (168.80) | (1,559.50) | (1,195.10) |
(3,275.50)
|
| ’24 | 71.10 | (1,269.70) | 791.90 | (352.80) |
(759.50)
|
| ’23 | (112.50) | (736.50) | 799.80 | 254.10 |
204.90
|
| ’22 | (371.70) | (186.80) | 300.00 | (120.80) |
(379.30)
|
| ’21 | 69.50 | 525.80 | 707.10 | 488.60 |
1,791.00
|
| ’20 | (245.90) | 169.00 | (33.70) | (58.60) |
(169.20)
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (1,270.50) | (32.50) | — | — |
—
|
| ’25 | (368.80) | (186.30) | (1,582.70) | (1,237.10) |
(3,374.90)
|
| ’24 | 56.90 | (1,287.40) | 772.80 | (379.50) |
(837.20)
|
| ’23 | (125.40) | (756.10) | 782.70 | 237.10 |
138.30
|
| ’22 | (1,002.40) | (191.90) | 292.40 | (136.40) |
(1,038.30)
|
| ’21 | 59.80 | 517.90 | 697.70 | 474.20 |
1,749.60
|
| ’20 | (259.10) | 158.50 | (47.30) | (82.50) |
(230.40)
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (0.37) | 0.37 | — | — |
—
|
| ’25 | 0.35 | 0.87 | 0.00 | 0.96 |
2.18
|
| ’24 | 0.18 | 0.40 | 1.63 | 0.57 |
2.77
|
| ’23 | 0.28 | (0.27) | 0.22 | (1.92) |
(1.68)
|
| ’22 | 1.57 | 0.67 | 0.77 | 0.35 |
3.35
|
| ’21 | 2.41 | 2.55 | 1.46 | 1.77 |
8.20
|
| ’20 | (1.76) | 0.41 | 0.82 | 1.44 |
0.97
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 24.59 | 25.20 | 36.65 | 33.02 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 56.00 | 42.49 | 55.11 | 69.85 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,100 | 2,200 | 2,300 | 2,500 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.11 | 1.35 | 2.36 | 1.91 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4,438.70 | 2,963.90 | 5,425.80 | 4,779.80 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | 100.00% | 100.00% | 100.00% | 100.00% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,572.50 | (600.90) | 1,393.70 | 1,159.20 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 35.43% | (20.27%) | 25.69% | 24.25% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,284.70 | (496.70) | 1,091.10 | 944.70 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 147.40 | 180.60 | 184.10 | 192.10 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 12.29 | 8.20 | 15.13 | 13.29 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 3.38 | (1.68) | 2.85 | 2.25 | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1.05) | 0.57 | (2.12) | (9.11) | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1.82) | (0.18) | (0.22) | (0.28) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (2.87) | 0.38 | (2.33) | (9.38) | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 18.88 | 16.01 | 17.70 | 19.62 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 361.28 | 361.40 | 358.58 | 359.68 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8.82 | 0.00 | 17.72 | 26.27 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.44 | 4.88 | 3.34 | 4.45 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.59 | 2.50 | 2.85 | 3.01 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.50 | 3.87 | 2.59 | 4.25 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (6.43) | (23.90) | (9.67) | (5.09) | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (379.30) | 204.90 | (759.50) | (3,275.50) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (659.00) | (66.60) | (77.70) | (99.40) | ‡‡‡‡‡ | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1,038.30) | 138.30 | (837.20) | (3,374.90) | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7,987.10 | 7,044.10 | 7,997.50 | 8,802.20 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8,176.90 | 8,767.50 | 9,007.70 | 13,423.00 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (4,161.50) | (2,975.90) | (4,025.40) | (935.00) | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6,821.30 | 5,784.50 | 6,347.60 | 7,057.10 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.74% | (2.86%) | 4.61% | 3.10% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 37.93% | (13.53%) | 36.86% | 10.63% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 19.56% | (9.65%) | 16.82% | 12.07% | — | — | — |
ROE
|
Carlyle Group Inc. (CG), a powerhouse in private equity, credit, and real assets managing over $400 billion in AUM, has demonstrated resilience amid macroeconomic turbulence, with 2024 revenue surging 83% to $5.43 billion and net income rebounding to $1.09 billion (EPS $2.85) from 2023 losses. Revenue per employee hit $2.36 million, underscoring operational leverage, while gross margins remain a perfect 100% in its asset-light model. Earnings swings tied to volatile performance fees and carried interest mirror PE cycles, with ROE at 17% in 2024 versus peaks of 69% in 2021, supported by a cash-rich balance sheet (net debt -$4.03 billion).
Valuation metrics suggest undervaluation at 17.7x P/E, 3.3x P/S, and 2.6x EV/Sales, trading flat to low-end analyst targets but with 23% consensus upside to $49% on projected EPS growth to $4.72 by 2027 (forward P/E 11-16x). Stock price tracks revenue and macro liquidity closely, positioning CG for re-rating if rates ease, unlocking $3 trillion in PE dry powder. Compared to peers like Blackstone and KKR, multiples imply relative appeal amid stabilizing M&A.
Insider selling (~$54 million in 2025) without buys signals caution, alongside a projected 2025 revenue dip to $3.82 billion before recovery. Tailwinds from potential Fed cuts and diversification into infrastructure hedge risks like prolonged high rates or recession, making CG a high-beta play on private markets’ $20 trillion AUM trajectory by 2030.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.